the former being in MLH1-dependent while the latter in MLH1-independent manner. Therefore, the signals delivered from different sources would merge at the step of Chk1 activation or at an earlier step, and the subsequent process leading to apoptosis appears to be common.
Introduction
Among the various types of drugs designed for use in cancer chemotherapy, many have the potential for alkylation. These chemicals alkylate DNA bases, thereby preventing the multiplication of rapidly growing tumor cells. These alkylating agents can be divided into at least three groups, according to their preferred sites of action and their ability to form interstrand crosslinks in DNA (1-7). The first group of agents is the monofunctional triazenes, which produce O 6 -methylguanine as the primary lesion for cell killing. The second group of agents is the bifunctional chloroethylnitrosoureas, which produce O 6 -chloroethylguanine in DNA. This modified base further reacts with a cytosine residue of the opposite strand to yield an interstrand crosslink in the DNA. The first and the second type of drugs can be represented by 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboximide (dacarbazine) and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU), respectively.
There is also a third type of drug, which acts on DNA in a different way. The last type of drugs, represented by cyclophosphamide, yield 7-substituted guanine and other alkylated bases, which also make crosslinks in the DNA. Reflecting the fact that the primary killing lesions induced by the first two classes of drugs are O by the two types of drugs cause different effects on the cellular DNA synthesis. O 6 -methylguanine, produced by dacarbazine, would allow progression of the DNA replication forks and, after one round of DNA replication, yield an O 6 -methylguanine-thymine mispair. It has been shown that such a mispair, synthesized in vitro, can be recognized by the mismatch recognition protein to activate ATR kinase (13) . In contrast, O 6 -chloroethylguanine, a bulky lesion produced by ACNU, and its resulting crosslink would prevent DNA replication and transcription, which itself induces apoptosis (14) . Important roles of MGMT and mismatch repair proteins on apoptosis induced by O 6 -methylguanine and
Survival of cells after drug treatment
Approximately 300 cells were placed in D-MEM-10% FCS in a well, incubated at 37°C for one day, and washed with phosphate-buffered saline (PBS antibodies. Antigens transferred were visualized using an enhanced chemiluminescence detection system (ECL: Amersham Biosciences) with a secondary goat IgG against rabbit or mouse IgG conjugated to horseradish peroxidase (Jackson ImmunoRes. Inc.). The signals obtained were quantified, using the LAS3000mini system (Fujifilm).
Determination of mutant frequency
To exclude any pre-existing HPRT-defective mutant cells, HeLa MR and SW48 cells were incubated in HAT medium containing 1 x 10 -4 M hypoxanthine, 5 x 10 -7 M amethopterin and 1 x 10 -5 M thymidine for 3 days and then in HAT medium without amethopterin for 3 days. The cells were then treated with dacarbazine or ACNU as described above, and then were incubated for 4 days to allow the expression of the 6-TG-resistant phenotype. After washing with PBS, (1-2) x 10 6 cells were incubated in D-MEM-10% FCS containing 6-TG (5 μg/ml) for seven days, and then the number of resistant colonies was counted. In parallel, a cell suspension containing approximately 500 cells was incubated in several 100-mm dishes and the number of viable cells was counted.
Analyses of chromatin-bound protein components
HeLa MR (ePMS2) cell line, stably expressing FLAG-tagged hPMS2 protein, was described previously (23). After the treatment with drugs, the cells were permeabilized and washed extensively on the dish with ice-cold buffer A (20 mM HEPES/KOH (pH 7.9), 5 mM KCl, 1.5 mM 
Detection of phosphorylated Chk1
The cells treated with dacarbazine or ACNU were incubated in 10% FCS-containing medium at 37°C.
At the appropriate times, the cells were collected and lysed with SDS-PAGE sample buffer (60 mM Tris⋅HCl (pH 6.8), 2% SDS, 10% glycerol, 100 mM DTT, and 0.001% bromophenol blue) containing phosphatase inhibitors (06863-01, Nacalai Tesque Inc.). After sonication, the cell debris was removed by centrifugation, and the extracts were applied to SDS-PAGE, followed by immunoblotting performed with the use of antibodies that specifically recognize Chk1 (Santa Cruz Biotechnology) and serine 317-phosphorylated Chk1 (Bethyl Laboratories, Inc.) proteins.
Assay of caspase-3 activity
The caspase-3 activity was determined according to the protocol of the EnzChek caspase-3 assay kit #2 (Molecular Probes). The hydrolysis products were quantified using a Wallace 1420 microplate counter ARVO (PerkinElmer). The values obtained with the inhibitor were subtracted from those obtained without the inhibitor, in order to express the specific activity of caspase-3.
Results

Sensitivity of human cells to dacarbazine and ACNU
-10 -Since dacarbazine must be activated before it can interact with DNA (6), the S9-mixture containing cytochrome P450-dependent oxidation enzymes was added to the cell cultures. Although ACNU acts on DNA without metabolic activation, the S9-mixture was also added to adjust the experimental conditions. Under these conditions, human cell lines having different capacities for DNA repair and related functions were exposed to the two types of drugs, and their survivals were determined ( Figure   1A and B). HeLa MR, which is deficient in O
6
-methylguanine-DNA methyltransferase activity, is considerably more sensitive to both dacarbazine and ACNU, than the wild-type strain, HeLa S3. It is evident, therefore, that the human methyltransferase is capable of repairing O 6 -methylguanine and O 6 -chloroethylguanine, which are produced by dacarbazine and ACNU, respectively.
SW48 cells, on the other hand, exhibit different responses to the two types of drugs. This cell line is as resistant to dacarbazine as is wild-type HeLa S3, but it exhibits an increased sensitivity to ACNU.
SW48 was originally isolated from human colorectal adenocarcinoma, and is known to have defects in various gene functions. It has been shown that SW48 cells lack methyltransferase activity and are devoid of MLH1 as well as MSH6 proteins, due to the transcriptional silencing of the genes (24,25). In addition, this cell line carries mutations in other genes, including those for DNA polymerase δ and transforming growth factor-β type receptor (26, 27) .
To resolve the complexity associated with the human tumor-derived cell line, we performed an RNA interference experiment. When two types of siRNAs (M1 and M2), which could bind to different regions of MLH1 mRNA, were applied to HeLa MR cells, the expression levels of the MLH1 protein in M1-and M2-treated cells were reduced to approximately 50% of the level of the control RNA-treated cells (Figure 2A ). Almost the same degree of reduction was observed with PMS2, which forms a complex with MLH1, consistent with the previous observation that these proteins are unstable unless they form a complex (28, 29) . In addition, these reduced levels of MLH1 as well as PMS2
protein were retained for at least 4 days while the survival assays were conducted by exposing the cells to the two types of drugs at two days after siRNA treatment. implying that SW48 cells would accumulate mutations, due to their inability for correcting errors associated with DNA replication. After treatment with dacarbazine, the mutant frequency of SW48 cells increases considerably, and the value reaches 6 times that of the same cells without drug treatment. In contrast, no significant increase in the mutant frequency was observed with SW48 cells treated with ACNU than with non-treated cells. These results suggest that dacarbazine-induced lesions can be processed through a pathway in which mismatch repair-related proteins are involved, whereas ACNU-induced cell death occurs without the involvement of these proteins.
Formation of a mismatch protein complex on damaged DNA
A protein complex composed of PCNA, MutSα (a heterodimer of MSH2 and MSH6) and MutLα (a heterodimer of MLH1 and PMS2) is formed on the chromosomal DNA when human cells deficient in O 6 -methylguanine-DNA methyltransferase activity are exposed to relatively low doses of MNU (13, 23) . To determine if such a complex is formed in the cells treated with these two types of drugs, the following experiment was performed. HeLa MR cells stably expressing FLAG epitope-tagged PMS2 (HeLa MR (ePMS2)) were treated with dacarbazine or ACNU for 4 h and further incubated in a drug-free growth medium. At certain times, the cells were permeabilized with digitonin and then treated with 3, 3'-dithiobis-sulfosuccinimidylpropionate (DTSSP) to stabilize protein complexes.
The chromatin fractions were prepared from these cells, and the mismatch-recognition protein complex was immunoprecipitated with an anti-FLAG antibody. The immunoprecipitated materials were treated with a reducing agent to cleave the cross-linking and then subjected to SDS-PAGE, followed by the detection of each component by specific antibodies.
To compare the effects of dacarbazine and ACNU, the concentrations of the two types of drugs were adjusted to comparable lethal levels on methyltransferase-deficient HeLa MR cells. These values were estimated from the survival curves shown in Figure 1 , where the LD 37 of MR cells for dacarbazine is 0.33 mM while the value for ACNU is 8.5 μM. The cells were therefore treated with 0.66 and 2 mM dacarbazine or 17 and 51 μM ACNU, which give 2 and 6 lethal hits, respectively. 
Phosphorylation of Chk1
The activation of ATR kinase causes the initiation of the signaling cascades which thus leads to cell cycle checkpoint and cell death in response to DNA replication fork block and DNA damage by alkylating agents (30) (31) (32) . We therefore have examined whether this activation occurs in response to dacarbazine and ACNU by monitoring Chk1 phosphorylation. For this, HeLa MR cells deficient in the methyltransferase activity were exposed to 2 mM dacarbazine or 51 μM ACNU, doses sufficient to induce apoptosis. Measurement of the caspase-3 activity confirmed that apoptosis was indeed induced under these conditions. Three days after exposure to dacarbazine and ACNU, the levels of caspase-3 activity increased 2.4 and 2.2 times that of untreated cells, respectively. The levels of phosphorylation of Chk1 protein was then measured, and the results are shown in Figure 5A . The amounts of phosphorylated Chk1 increase after treatment of cells with either type of drugs.
Furthermore, the dacarbazine-induced Chk1 phosphorylation occurs in HeLa MR cells, but not in SW48 cells, which lack both MGMT and MLH1 functions, whereas the ACNU-induced phosphorylation proceeds equally well in both HeLa MR and SW48 cells ( Figure 5B ). Therefore, the signals initiated from the two different types of DNA lesions, which are delivered in mismatch protein-dependent and -independent manners, appear to merge at the point of Chk1 phosphorylation or earlier ( Figure 6 ). MMR complex: mismatch recognition protein complex.
Discussion
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